Zentalis Pharmaceuticals, Inc.

By person

25 insiders · 464 transactions

0.3×

Julie Eastland holds only 0.3 times base salary in stock. $276.97K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Julie Eastland last reported holding, valued at $3.50, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Matrix Capital Management Company, LP entity

10% owner

$107.86M (1)

$9.98M (1)

+$97.89M

6,459,973

9.01%

$22.61M

−29.8%

SUN ANTHONY Y

President & CEO

$15.98K (1)

$32.77M (106)

−$32.75M

3,691,443

5.15%

$12.92M

−5.7%

WALTERS GROUP entity

10% owner

$22.92M (2)

—

+$22.92M

17,844,973

24.90%

$62.46M

+153.1%

Gallagher Cam

President, Interim CFO

—

$21.22M (131)

−$21.22M

633,680

0.8841%

$2.22M

+8.9%

Bunker Kevin D.

Chief Scientific Officer

$6.30K (1)

$20.77M (113)

−$20.76M

866,771

1.21%

$3.03M

−20.9%

VIKING GLOBAL INVESTORS LP entity

10% owner

$13.05M (1)

$25.25M (1)

−$12.20M

3,943,284

5.50%

$13.80M

+6.1%

Epperly Melissa B,

Chief Financial Officer

$859.75K (3)

$4.01M (46)

−$3.15M

451,449

0.6299%

$1.58M

+241.5%

Pinto Alexis

Chief Legal Officer

—

$2.37M (6) scheduled

−$2.37M

22,240

0.0310%

$77.84K

+7,958%

Voliotis Dimitris

SVP, Clinical Development

—

$1.87M (11) scheduled

−$1.87M

15,978

0.0223%

$55.92K

—

Johnson David Michael

Director

$239.94K (2)

$2.08M (8)

−$1.84M

307,521

0.4291%

$1.08M

+399.5%

Blackwell Kimberly

Chief Executive Officer

$51.45K (1)

$323.63K (4) scheduled

−$272.18K

484,145

0.6755%

$1.69M

—

Brownstein Carrie

Chief Medical Officer

—

$207.30K (2) scheduled

−$207.30K

105,685

0.1475%

$369.90K

—

Vultaggio Vincent

PAO and PFO

—

$115.01K (7) scheduled

−$115.01K

146,506

0.2044%

$512.77K

+313.2%

Paul Andrea

Chief Legal Officer

—

$60.84K (2)

−$60.84K

1,070,784

1.49%

$3.75M

—

Lackner Mark

Chief Scientific Officer

—

$56.64K (3)

−$56.64K

512,856

0.7156%

$1.79M

+3,044%

HAUSMAN DIANA

Chief Medical Officer

—

$42.35K (1)

−$42.35K

373,876

0.5216%

$1.31M

—

Bruns Ingmar

Chief Medical Officer

$45.66K (1)

$8.00K (2)

+$37.66K

33,332

0.0465%

$116.66K

—

Myers Scott Dunseth

Director

$29.37K (1)

—

+$29.37K

395,895

0.5524%

$1.39M

—

EASTLAND JULIA MARIE

CEO & President

$49.34K (1)

$21.24K (2)

+$28.11K

79,133

0.1104%

$276.97K

—

Walker Luke Nathaniel

Director

$24.97K (1)

—

+$24.97K

201,384

0.2810%

$704.84K

—

Skvarka Jan

Director

$103.45K (1)

$125.24K (1) scheduled

−$21.79K

264,254

0.3687%

$924.89K

—

Kariuki Enoch

Director

—

194,465

0.2713%

$680.63K

—

Campbell Shannon

Director

—

114,200

0.1593%

$399.70K

—

Roth Iris

Chief Operating Officer

—

52,500

0.0733%

$183.75K

—

Recurium Equity, LLC entity

10% owner

—

14,990

0.0209%

$52.47K

−99.6%

Individual transactions

Insider

Date

Role

Action

Price

Amount

WALTERS GROUP

14 Aug 2026

10% owner

Buy

4,335,000

$3.50

$15.17M

WALTERS GROUP

31 Dec 2025

10% owner

Buy

6,459,973

$1.20

$7.75M

Myers Scott Dunseth

30 Apr 2025

Director

Buy

21,000

$1.40

$29.37K

Bruns Ingmar

6 Feb 2025

Chief Medical Officer

Buy

20,000

$2.28

$45.66K

EASTLAND JULIA MARIE

31 Jan 2025

CEO & President

Buy

28,500

$1.73

$49.34K

Walker Luke Nathaniel

31 Jan 2025

Director

Buy

14,200

$1.76

$24.97K

Skvarka Jan

31 Jan 2025

Director

Buy

60,000

$1.72

$103.45K

Blackwell Kimberly

13 Nov 2023

Chief Executive Officer

Buy

5,000

$10.29

$51.45K

Johnson David Michael

10 Nov 2023

Director

Buy

17,000

$9.88

$167.94K

Matrix Capital Management Company, LP

20 Jun 2023

10% owner

Buy indirect

4,760,000

$22.66

$107.86M

Showing 250 of 464 transactions. The figures above use every one of them.

Zentalis Pharmaceuticals, Inc.

By person

Individual transactions

What was left out